title: ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
authors.forename: Andy
authors.initials: A
authors.lastname: Lo
authors.forename: Guangyu
authors.initials: G
authors.lastname: Gu
authors.forename: Mingya
authors.initials: M
authors.lastname: Liu
authors.forename: Vaithilingam G
authors.initials: VG
authors.lastname: Dev
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017353:Gene Deletion; D016313:Genes, abl; D006801:Humans; D008297:Male; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide